Executive record

Nicholas M. Maestas

Most recent record: Rani Therapeutics Holdings, Inc. CFO transition: Nicholas M. Maestas to succeed Svai Sanford (named as the incoming officer), effective June 29, 2026. See Rani Therapeutics Holdings, Inc..

1 verified record

2026-06-30 · Transition

Rani Therapeutics Holdings, Inc. CFO transition: Nicholas M. Maestas to succeed Svai Sanford

This page lists only verified filing records that name Nicholas M. Maestas; it is not a career history. Corrections: the corrections page.